Aarey Drugs & Pharmaceuticals quarterly results and financials

Aarey Drugs & Pharmaceuticals (AAREYDRUGS)₹109.04−0.16%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Mar 2026 quarter (standalone), Aarey Drugs & Pharmaceuticals reported sales of ₹190 Cr, up 75.4% from Mar 2025, and net profit of ₹1.55 Cr, up 237.0% year on year. For the year to Mar 2026, sales were ₹474 Cr and net profit ₹3.99 Cr.

Sales (Mar 2026): ₹190 Cr
Net profit (Mar 2026): ₹1.55 Cr
Sales (FY Mar 2026): ₹474 Cr
Net profit (FY Mar 2026): ₹3.99 Cr
EPS (Mar 2026): ₹0.56
Borrowings (Mar 2026): ₹49.82 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

Aarey Drugs & Pharmaceuticals quarterly results

₹ crore unless stated; each column is a quarter.

Aarey Drugs & Pharmaceuticals Quarterly results
	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	51.16	58.03	76.73	211	127	106	134	108	103	84.49	96.75	190
Expenses	49.53	55.92	73.70	212	125	101	131	112	100	81.35	97.74	185
Operating Profit	1.35	1.85	2.71	−1.45	1.19	3.74	2.21	−4.22	1.72	2.65	−1.52	4.36
OPM %	2.6%	3.2%	3.5%	−0.7%	0.9%	3.6%	1.7%	−3.9%	1.7%	3.2%	−1.6%	2.3%
Other Income	0.69	0.83	0.28	5.13	1.57	0.01	0.67	7.53	1.54	0.78	4.17	−0.42
Interest	0.43	0.42	0.48	0.41	0.97	0.50	0.59	1.31	1.05	1.27	0.93	1.79
Depreciation	0.90	1.28	1.07	1.16	0.48	1.52	0.91	0.42	0.50	0.70	0.84	0.86
Profit before tax	0.72	0.99	1.45	2.14	1.32	1.73	1.39	1.61	1.72	1.47	0.91	1.27
Tax %	0.0%	−22.0%	30.1%	−0.5%	6.8%	8.6%	48.5%	71.6%	20.8%	31.1%	38.0%	−21.9%
Net Profit	0.71	1.22	1.01	2.14	1.23	1.59	0.71	0.46	1.36	1.01	0.56	1.55
EPS (Rs)	0.29	0.49	0.41	0.78	0.45	0.58	0.26	0.18	0.49	0.37	0.21	0.56

Aarey Drugs & Pharmaceuticals profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Aarey Drugs & Pharmaceuticals Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	247	397	350	355	299	350	495	421	398	476	474	474
Expenses	245	385	341	346	294	343	480	410	390	470	464	464
Operating Profit	1.01	10.04	8.04	8.04	3.01	5.02	11.05	8.03	4.01	3.01	7.03	7.21
OPM %	0.4%	2.4%	2.2%	2.2%	1.1%	1.3%	2.3%	1.8%	1.1%	0.6%	1.5%	1.5%
Other Income	2.99	2.99	2.99	3.99	6.99	6.99	2.99	2.99	6.99	9.98	5.99	6.07
Interest	2.01	4.01	2.01	2.01	2.01	2.01	2.01	3.01	4.01	5.01	5.01	5.04
Depreciation	1.01	1.01	1.01	1.01	1.01	1.01	2.01	2.01	2.01	2.01	3.01	2.90
Profit before tax	1.99	7.99	7.99	8.98	6.99	7.99	9.99	5.99	4.99	5.99	4.99	5.37
Tax %	29.0%	31.0%	24.9%	27.0%	20.0%	20.9%	35.0%	37.0%	12.0%	34.0%	27.0%	—
Net Profit	0.99	4.99	5.98	6.97	5.98	6.98	6.98	3.99	4.98	3.99	3.99	4.48
EPS (Rs)	0.78	3.03	2.65	2.81	2.49	2.79	2.59	1.50	1.68	1.43	1.41	1.63
Dividend payout %	0.0%	0.0%	0.0%	4.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Aarey Drugs & Pharmaceuticals balance sheet

₹ crore, at each year end.

Aarey Drugs & Pharmaceuticals Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	17.04	17.05	18.06	23.01	23.00	23.02	23.05	25.03	25.05	28.00	28.07	27.99
Reserves	19.01	20.02	31.01	56.95	62.95	68.91	75.03	87.96	92.05	105	110	122
Borrowings	10.96	14.96	9.97	2.99	15.95	17.94	17.94	13.95	37.88	30.90	34.88	49.82
Other Liabilities	68.69	73.76	82.65	85.59	42.80	83.59	115	116	135	138	116	96.53
Total Liabilities	115	125	142	170	146	193	232	244	290	302	290	296
Fixed Assets	6.01	8.02	12.05	12.03	12.04	12.03	14.05	14.04	14.04	13.04	16.06	26.07
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.01	1.99	2.01
Other Assets	109	117	130	157	133	180	217	229	276	288	271	268
Inventories	3.99	1.99	4.98	14.96	20.95	16.97	17.95	13.96	28.95	34.92	44.87	41.90
Trade receivables	67.01	71.99	82.08	95.03	106	95.99	162	136	190	184	133	130
Cash & equivalents	0.00	2.01	1.01	3.01	0.00	0.00	1.01	0.00	1.01	1.99	1.01	1.01
Total Assets	115	125	142	170	146	193	232	244	290	302	290	296

Aarey Drugs & Pharmaceuticals cash flow

₹ crore, for each year.

Aarey Drugs & Pharmaceuticals Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	3.01	6.02	1.01	−20.08	1.01	3.01	5.02	0.00	−1.01	−3.01	10.03	10.03
Cash from investing activity	−1.99	−2.99	−4.99	−0.99	−0.99	−0.99	−2.99	−2.99	0.00	−1.99	−5.98	−11.97
Cash from financing activity	−2.01	−2.01	4.01	23.03	−2.01	−2.01	−2.01	2.01	1.01	5.99	−4.01	1.99
Net cash flow	−1.01	1.01	−0.99	1.99	−3.01	0.00	0.00	0.00	1.01	0.99	0.00	0.00
Capex	2.42	2.59	4.93	0.61	1.22	0.93	2.87	2.21	1.05	0.73	5.19	12.42
Free cash flow	0.99	2.99	−3.99	−20.94	−0.99	1.99	2.99	−1.99	−1.99	−3.99	4.99	−1.99
CFO / OP %	238.9%	560.0%	28.0%	−232.1%	37.0%	135.0%	154.0%	36.0%	12.9%	−37.0%	421.0%	163.9%

Aarey Drugs & Pharmaceuticals ratios

Working-capital days and returns, by year.

Aarey Drugs & Pharmaceuticals Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	115	109	76	101	110	119	171	102	166	171	104	101
Inventory days	7	3	5	16	23	21	20	11	26	33	36	33
Days payable	117	108	71	84	40	98	120	86	115	123	81	66
Cash conversion cycle	5	3	9	32	92	42	69	26	76	80	58	68
Working capital days	49	40	34	69	77	99	91	68	89	106	89	90
ROCE %	7.0%	7.0%	21.9%	13.9%	11.9%	7.9%	8.9%	9.9%	6.0%	6.0%	6.0%	6.0%

Aarey Drugs & Pharmaceuticals: frequently asked questions

What are the latest quarterly results of Aarey Drugs & Pharmaceuticals?

For the Mar 2026 quarter, Aarey Drugs & Pharmaceuticals reported sales of ₹190 Cr, up 75.4% year on year and net profit of ₹1.55 Cr, up 237.0% year on year. The operating margin was 2.3%.

What is the annual revenue of Aarey Drugs & Pharmaceuticals?

Aarey Drugs & Pharmaceuticals' sales for the year to Mar 2026 were ₹474 Cr; over the last twelve months they were ₹474 Cr.

What is the net profit of Aarey Drugs & Pharmaceuticals?

Net profit for the year to Mar 2026 was ₹3.99 Cr, and ₹4.48 Cr over the last twelve months. Earnings per share over the same trailing period were ₹1.63.

How much debt does Aarey Drugs & Pharmaceuticals have?

Aarey Drugs & Pharmaceuticals reported borrowings of ₹49.82 Cr at Mar 2026, against cash and equivalents of ₹1.01 Cr.

What is the free cash flow of Aarey Drugs & Pharmaceuticals?

Cash from operations was ₹10.03 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹1.99 Cr.

Loading…